Deep Brain Stimulation (DBS) Data Base Study

Sponsor
St. Joseph's Hospital and Medical Center, Phoenix (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT01909531
Collaborator
(none)
5,000
1
129
38.8

Study Details

Study Description

Brief Summary

The primary goal of this study is to evaluate and compare outcomes, trends, and effectiveness of both awake and asleep Deep Brain Stimulation (DBS) surgical treatments, target selection, targeting accuracy and outcomes in patients with Parkinson's disease and Essential tremor.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Deep Brain Stimulation (DBS) surgery is a treatment that can improve some of the motor symptoms associated with several movement disorder diseases. DBS is recommended for patients with Parkinson's disease who respond well to medication, but still experience frequent wearing off of medications with return of symptoms. Patients may also be experiencing troubling medication side effects such as dyskinesias, sleepiness, hallucinations, confusion, and behavioral/personality changes. DBS is also used for patients with Essential tremor who have undergone long trials of medication therapy and are still symptomatic. The goal of DBS surgery is to capture that best response to medication and hold it through the day. The Food and Drug Administration (FDA) approved DBS as a treatment for essential tremor in 1997 and for Parkinson's disease in 2002.

    The goal of DBS surgery is to improve the quality of life of patients and their families by reducing motor symptoms such as slowness, stiffness and tremor and possibly reducing medication. In order to help with our understanding of its effects, we will collect information on patients who will be undergoing or have undergone DBS surgery.

    St. Joseph's Hospital and Medical Center / Barrow Neurological Institute is one of only a few hospitals in the United States offering a new procedure known as asleep DBS surgery, performed under general anesthesia, as well as the traditional awake DBS procedure; therefore it is important that this new asleep surgery option be studied and compared to awake DBS surgery.

    Objectives include:
    • Comparison of data collected for both the awake and asleep DBS procedures during the pre-operative and post-operative periods including testing, diagnosis, surgical treatment, target accuracy, complications, motor function and quality of life outcomes.

    • Comparison of the differential effects of STN and GPi DBS on gait and balance control

    • Investigate the effects of DBS on the saccadic eye movements.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    5000 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Deep Brain Stimulation (DBS) Data Base Study
    Study Start Date :
    Apr 1, 2013
    Anticipated Primary Completion Date :
    Dec 31, 2023
    Anticipated Study Completion Date :
    Dec 31, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Data Comparison [Pre-operative through 6 months post operative]

      Data comparison for pre-operative testing, diagnosis, surgical treatment, target accuracy, complications and outcomes for patients undergoing DBS surgery will be analyzed.

    Secondary Outcome Measures

    1. Quantitative Evaluation of Balance and Gait [Pre-operative through 6 months post-operative]

      For the quantitative evaluation of gait and balance control, different parameters of gait and balance will be obtained non-invasively during pre- and post-surgical clinical evaluation sessions. For this data collection, patients will be asked to perform many trials of quiet standing (eyes open and eyes closed conditions), postural shifts, stepping-in-place, and regular and tandem walking. These data will be obtained using a portable gait system (consisted of small light-weight sensors) and force plate setup. During balance tests, the patients will be asked to hold on to railings in case of loss of balance and asked to wear gait belt during these evaluations. A member of the research team will be close to the patient to hold them in case of any loss of balance to avoid falls.

    Other Outcome Measures

    1. Quantitative Evaluation of Saccadic Eye Movements [Pre-operartive - 6 months post-operative]

      Non-invasively record eye movements when patients follow target (light dot on a light bar placed in front of the patients) that jumps, moves back and forth, fixation on target, etc. This data collection will be obtained in a seated position.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Clinical diagnosis for Parkinson's Disease or Essential Tremor

    • Subject has undergone DBS surgery

    Exclusion Criteria:
    • Clinical diagnosis for Parkinson's Disease or Essential Tremor

    • Subject has not undergone DBS surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 St. Joseph's Hospital & Medical Center / Barrow Neurological Institute Phoenix Arizona United States 85013

    Sponsors and Collaborators

    • St. Joseph's Hospital and Medical Center, Phoenix

    Investigators

    • Principal Investigator: Francisco A Ponce, MD, St. Joseph's Hospital & Medical Center / Barrow Neurological Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    St. Joseph's Hospital and Medical Center, Phoenix
    ClinicalTrials.gov Identifier:
    NCT01909531
    Other Study ID Numbers:
    • 12BN136
    First Posted:
    Jul 26, 2013
    Last Update Posted:
    Sep 16, 2021
    Last Verified:
    Sep 1, 2021
    Keywords provided by St. Joseph's Hospital and Medical Center, Phoenix
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 16, 2021